In a recent press release, Medtronic plc (NYSE:MDT), the global leader in medical technology, announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved ...
More than 26,000 complaints have been reported over the use of MiniMed 600 Series insulin pumps Medical device company Medtronic has recalled two of its MiniMed insulin pumps over incorrect dosing.
The FDA announced that Medtronic expanded two recalls relating to the MiniMed 600 series of insulin pumps and MiniMed 508 remote controllers. Both were designated by the agency as Class I, the most ...
Medtronic plc, the global leader in medical technology, announced the US commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved for the treatment of people with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback